Editor’s note: This is a sponsored article, which means it’s independently written by our editorial team but financially supported by another organisation, in this case, Merck. If you would like to learn more about sponsored posts on Tech.eu, read this and contact us if you’re interested in partnering with us.

Merck, one of the largest pharmaceutical companies in the world, is looking for relevant startups to partner with and co-create new solutions. To do this, the company has established the Merck Accelerator program, which is open for applications now but, perhaps curiously, isn’t really meant to ‘accelerate’ third-party startups as such.

Or, at least, that’s just part of what Merck is offering; the real purpose is to find 12 relevant startups that they can finance – but